Anti-estrogen medication reduces risk of dying from lung cancer

	Tweet

A new study has found that tamoxifen, an anti-estrogen breast cancer medication, may reduce an individual’s risk of death from lung cancer. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study supports the hypothesis that there is a hormonal influence on lung cancer and that estrogen levels play a role in lung cancer patients’ prognosis.

Previous research suggests that menopausal hormone therapy increases women’s risk of dying from lung cancer. If this is true, the use of anti-estrogens should have the opposite effect. Elisabetta Rapiti, MD, of the Geneva Cancer Registry led a study that compared lung cancer incidence and mortality among breast cancer patients who were and were not treated with anti-estrogen therapy. The study included all 6,655 women diagnosed with breast cancer between 1980 and 2003 and registered at the Geneva Cancer Registry. Among these women, 46 percent (3,066) received anti-estrogens. All women were followed for occurrence and death from lung cancer until December 2007.

The investigators found that 40 women in the study developed lung cancer. Incidences of lung cancer was not significantly different between breast cancer patients who were and were not treated with anti-estrogens compared with the general population; however, fewer women taking anti-estrogens died from lung cancer than expected. Specifically, there were 87 percent fewer cases of death due to lung cancer in the anti-estrogen group than in the general population.

"Our results support the hypothesis that there is a hormonal influence on lung cancer which has been suggested by findings such as the presence of estrogen and progesterone receptors in a substantial proportion of lung cancers,” said Dr. Rapiti. “If prospective studies confirm our results and find that anti-estrogen agents improve lung cancer outcomes, this could have substantial implications for clinical practice,” she added.

###

Contact: Jennifer Beal

44-124-377-0633
Wiley-Blackwell

RELATED STORIES:
Lung Cancer Experts Address Smoking Dangers on Kick Butts Day   Counting lung cancer cells helps predict disease   Long-Term Use of Nutrient Supplements May Increase Cancer Risk   Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer   Vaccination with embryonic stem cells prevents lung cancer in mice   Gold nanotech breath test may show lung cancer early   Radiation-Armed Robot Rapidly Destroys Human Lung Tumors   Bone drug zoledronic acid may help prevent spread of early lung cancer   Gene Panel Predicts Lung Cancer Survival   M. D. Anderson research links diet, gardening and lung cancer risk   CT Screening for Lung Cancer Cost-Effective   Researchers Identify Tumor-Suppressor Gene for Lung Cancer   Tooth Loss Linked to Esophageal, Head and Neck, and Lung Cancer   Hormone replacement tied to lung cancer risk   New lung cancer staging system revealed   Quitting Smoking After Lung Cancer Diagnosis Can Prolong Life   Cigar, pipe smoking may raise lung disease risk, too   Low-dose CT screening may benefit individuals at increased risk for lung cancer   Small Steps Toward Lung Cancer Relief   Molecular subtypes and genetic alterations may determine response to lung cancer therapy   Ovary removal may raise risk of lung cancer   Lung cancer risk increases with expression of specific genes

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]